Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
This activity is supported by an educational grant from Celgene.
Management of Venous Thromboembolism for Patients with Hematologic Malignancies
Rowena N. Schwartz, PharmD, BCOP
University of Cincinnati
Advanced practitioners (APs) are an integral part of the cancer care team. Therefore, it is imperative they are knowledgeable of risk factors associated with venous thromboembolism (VTE) in the oncology setting, including signs or symptoms and management. Early intervention is crucial. APs must also be able to differentiate between anticoagulation drugs and select the appropriate treatment for their patient with VTE. This educational program will provide the AP with an overview of VTE risks in cancer patients, indications and contraindications for prophylaxis or treatment, antidotes/reversal agents, and patient monitoring.
These CME/CE/CPE accredited activities are jointly provided by
